Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression

被引：0
|
作者：
Bun'kova, K. M. [1 ]
机构：
[1] IM Sechenov Med Acad, Moscow, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2008年 / 108卷 / 03期
关键词：
depression; psychopharmacotherapy; predictors; antidepressants;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The open comparative study of three antidepressants with different mechanisms of action - clomipramine, pirlindole and escitalopram - in the treatment of neurotic level depression (ICD-10 items F32-F34, F43) has been carried out. Ninety-one patients have been stratified into three groups included 31, 31 and 29 patients, respectively.. Duration of the study has been 12 weeks. Clomipramine, pirlindole and escitalopram have similar effect decreasing the total HAM-D score by more than 50% (in average 72%). Clomipramine appears to be more effective in the achievement of remission (63%) as compared to pirlindole (40%) and escitalopram (42%). The tolerability of pirlindole and escitalopram is higher than that of clomipramine and the authors recommend prescription of these drugs to patients with neurotic depression.
引用
收藏
页码：29 / 32
页数：4
相关论文
共 50 条
  • [1] Escitalopram: efficacy and tolerability in ther treatment of depression
    Baldwin, DS
    HOSPITAL MEDICINE, 2002, 63 (11): : 668 - 671
  • [2] A comparison of efficacy and tolerability of Vilazodone and Escitalopram in the management of depression
    Duraisamy, Karthik
    Selvan, C. Panneer
    INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S143 - S143
  • [3] A COMPARISON OF CLOMIPRAMINE AND DOXEPIN IN NEUROTIC DEPRESSION
    KORNHABER, A
    HORWITZ, IM
    JOURNAL OF CLINICAL PSYCHIATRY, 1984, 45 (08) : 337 - 341
  • [4] Efficacy and tolerability of escitalopram in patients with depression vs depression with comorbid anxiety
    Lampousi, E.
    Stamouli, S.
    Liakouras, A.
    Panagoutsos, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S355 - S356
  • [5] Efficacy and tolerability of escitalopram in the treatment of anxiety disorders
    Pollack, MH
    Bose, A
    Zheng, H
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S344 - S344
  • [6] Efficacy and tolerability of Escitalopram in patients with mild, moderate and severe depression
    Stamouli, S.
    Yfantis, A.
    Zouganelli, A.
    Lampousis, E.
    Giailoglou, D.
    Parashos, I.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 320 - 320
  • [7] The efficacy and the tolerability of escitalopram in the treatment of premenstrual dysphoric disorder
    Ladea, Maria
    Sarpe, M. C.
    Dumitreseu, Mihaela Ruxandra
    GINECO RO, 2008, 4 (04): : 253 - 258
  • [8] Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
    Shao, Shichuan
    Sun, Baomin
    Sun, Huiqing
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (05) : 1389 - 1394
  • [9] Efficacy and tolerability of Escitalopram in patients suffering from depression with or without comorbid disorders
    Kodounis, A.
    Stamouli, S.
    Vlisidis, D.
    Karavatos, A.
    Papalexi, E.
    Parashos, I. A.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 41 - 41
  • [10] Efficacy and tolerability of Escitalopram in patients with moderate to severe depression with or without comorbid anxiety
    Stamouli, S.
    Vidalis, A.
    Stathakis, I.
    Bastas, H.
    Koulis, S.
    EUROPEAN PSYCHIATRY, 2008, 23 : S207 - S207
12345